title: Patient and graft survival after pre-emptive versus non-pre-emptive kidney transplantation: a single-center experience from Turkey.
abstract: OBJECTIVE
  We sought to report the graft and patients survival of pre-emptive and non-pre-emptive kidney transplantations performed in our center.
  
  
  METHODS
  The 859 subjects showed a mean age of 36.1 years and included 64.6%; males, who received grafts from living (n = 665) or deceased (n = 194) donors between January 2008 and June 2011. We reviewed their medical records retrospectively, to separately pre-emptive versus non-pre-emptive recipients for year transplant outcomes.
  
  
  RESULTS
  Among the 859 patients, 153 (17.8%) underwent pre-emptive and 706 (82.2%), non-pre-emptive kidney transplantations. The rate of living donors was higher in the pre-emptive group (97.4% vs 73%, respectively). The 1-year graft survivals were 99.3% and 95.8% in pre-emptive and non-pre-emptive transplantation groups, respectively (P > .05). There was no significant difference between groups with respect to patient survival at 1 year (P > .05).
  
  
  CONCLUSIONS
  In conclusion, graft and patient survival rates between pre-emptive and non-pre-emptive kidney transplantation cases were comparable at 1 year. Pre-emptive kidney transplantation, which eliminates hemodialysis costs and complications, should be preferred as the optimal renal replacement therapy for end-stage renal disease patients.
authors.affiliation: Atatürk Training and Research Hospital, Clinic of Surgery, Organ Transplantation Center, Ankara, Turkey. birkan.bozkurt@gmail.com
authors.forename: B
authors.initials: B
authors.lastname: Bozkurt
authors.forename: A Ö
authors.initials: AÖ
authors.lastname: Kumru
authors.forename: E G
authors.initials: EG
authors.lastname: Dumlu
authors.forename: M
authors.initials: M
authors.lastname: Tokaç
authors.forename: H
authors.initials: H
authors.lastname: Koçak
authors.forename: G
authors.initials: G
authors.lastname: Süleymanlar
authors.forename: A
authors.initials: A
authors.lastname: Dinçkan
mesh_terms: D000328:Adult; D005260:Female; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D015996:Survival Rate; D014421:Turkey